Major insurance companies are throwing their weight behind federal legislation that would allow them to serve cannabis businesses, a move that could finally bring mainstream coverage to an industry that has struggled with limited options for years.
The Cannabis Limited Access to Insurance for Marijuana (CLAIM) Act addresses the same federal-state conflict that has kept traditional insurers out of the sector—a problem that won't disappear even if the DEA moves marijuana to Schedule III. The bill has attracted support from large insurers who have been unable to enter the market due to concerns about federal illegality.
"This is similar to what we've seen with SAFE Banking," said one industry analyst familiar with the legislation. The comparison is apt: both bills target the gap between state-legal cannabis operations and federal prohibition that has forced the industry to rely on specialized, often expensive insurance providers.
Why Rescheduling Won't Fix It
The push for the CLAIM Act comes as the cannabis industry awaits final action on marijuana rescheduling. But insurance experts say moving cannabis to Schedule III won't necessarily open the floodgates for traditional carriers.
Federal banking regulations and compliance requirements still create significant barriers for insurers, even if the substance is rescheduled. Many large insurance companies operate across state lines and maintain federal contracts, making them hesitant to serve cannabis clients without explicit legal protection.
The lack of mainstream insurance has been a persistent problem for cannabis operators. Many businesses pay premiums two to three times higher than comparable non-cannabis companies, and some struggle to find coverage for basic needs like property insurance or general liability.
Industry Response
Cannabis business owners have long cited insurance as one of their top operational challenges. The current market is dominated by a handful of specialty insurers who understand the space but can charge premium rates due to limited competition.
Mainstream insurers entering the market would likely drive down costs through increased competition. It would also signal a broader normalization of cannabis as a legitimate business sector, something that could have ripple effects for banking, investment, and other financial services.
The CLAIM Act would provide clear legal pathways for insurers to work with state-licensed cannabis businesses without fear of federal prosecution or regulatory penalties. That's the same basic framework that SAFE Banking has proposed for financial institutions—creating a safe harbor for companies serving legal cannabis operations.
What's Next
The bill's prospects in Congress remain uncertain. SAFE Banking has passed the House multiple times but stalled in the Senate, suggesting that cannabis-adjacent financial legislation faces an uphill battle despite growing industry support.
But the involvement of major insurance companies could change the political calculus. Large insurers carry significant lobbying weight, and their backing might help push the legislation forward where cannabis advocates alone have struggled.
For now, cannabis operators continue to navigate a fragmented insurance market while watching both the CLAIM Act and rescheduling efforts. The industry's hope is that one or both will finally bring relief on the insurance front.
This article is based on original reporting by mjbizdaily.com.
